IO Biotech, Inc. (IOBT)
(Real Time Quote from BATS)
$1.52 USD
-0.01 (-0.65%)
Updated May 3, 2024 03:08 PM ET
3-Hold of 5 3
D Value C Growth C Momentum D VGM
Cash flow Statements
Fiscal Year End for IO Biotech, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -86.08 | -71.46 | -67.88 | -12.04 | NA |
Depreciation/Amortization & Depletion | 0.22 | 0.10 | 0.00 | 0.00 | NA |
Net Change from Assets/Liabilities | 5.86 | 4.19 | -0.78 | 0.15 | NA |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Operating Activities | 8.27 | 7.43 | 28.01 | 1.94 | NA |
Net Cash From Operating Activities | -71.74 | -59.73 | -40.65 | -9.96 | NA |
Property & Equipment | -0.32 | -0.69 | -0.15 | 0.00 | NA |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Net Cash from Investing Activities | -0.32 | -0.69 | -0.15 | 0.00 | NA |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 75.06 | 0.00 | 265.06 | 5.12 | NA |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | NA |
Other Financing Activities | -3.20 | 0.00 | -12.11 | -0.01 | NA |
Net Cash from Financing Activities | 71.86 | 0.00 | 252.95 | 5.10 | NA |
Effect of Exchange Rate Changes | 0.80 | -8.52 | -3.76 | 0.41 | NA |
Net Change In Cash & Equivalents | 0.60 | -68.94 | 208.39 | -4.44 | NA |
Cash at Beginning of Period | 142.86 | 211.80 | 3.41 | 7.85 | NA |
Cash at End of Period | 143.46 | 142.86 | 211.80 | 3.41 | NA |
Diluted Net EPS | -1.98 | -2.48 | -17.30 | NA | NA |
Fiscal Year End for IO Biotech, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -86.08 | -59.90 | -38.22 | -17.04 |
Depreciation/Amortization & Depletion | NA | 0.22 | 0.16 | 0.10 | 0.05 |
Net Change from Assets/Liabilities | NA | 5.86 | 3.83 | 1.67 | 0.55 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 8.27 | 6.97 | 3.50 | 1.76 |
Net Cash From Operating Activities | NA | -71.74 | -48.94 | -32.95 | -14.69 |
Property & Equipment | NA | -0.32 | -0.21 | -0.19 | -0.15 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | -0.32 | -0.21 | -0.19 | -0.15 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 75.06 | 75.06 | 0.00 | 0.00 |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | -3.20 | -3.19 | 0.00 | 0.00 |
Net Cash from Financing Activities | NA | 71.86 | 71.87 | 0.00 | 0.00 |
Effect of Exchange Rate Changes | NA | 0.80 | 0.19 | 0.64 | 0.78 |
Net Change In Cash & Equivalents | NA | 0.60 | 22.91 | -32.50 | -14.06 |
Cash at Beginning of Period | NA | 142.86 | 142.86 | 142.86 | 142.86 |
Cash at End of Period | NA | 143.46 | 165.77 | 110.36 | 128.80 |
Diluted Net EPS | NA | -0.22 | -0.43 | -0.74 | -0.59 |